Asset Details
Do you wish to reserve the book?
Mediator MED23 regulates inflammatory responses and liver fibrosis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mediator MED23 regulates inflammatory responses and liver fibrosis
Do you wish to request the book?
Mediator MED23 regulates inflammatory responses and liver fibrosis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mediator MED23 regulates inflammatory responses and liver fibrosis
2019
Overview
Liver fibrosis, often associated with cirrhosis and hepatocellular carcinomas, is characterized by hepatic damage, an inflammatory response, and hepatic stellate cell (HSC) activation, although the underlying mechanisms are largely unknown. Here, we show that the transcriptional Mediator complex subunit 23 (MED23) participates in the development of experimental liver fibrosis. Compared with their control littermates, mice with hepatic Med23 deletion exhibited aggravated carbon tetrachloride (CCl4)-induced liver fibrosis, with enhanced chemokine production and inflammatory infiltration as well as increased hepatocyte regeneration. Mechanistically, the orphan nuclear receptor RAR-related orphan receptor alpha (RORα) activates the expression of the liver fibrosis-related chemokines C-C motif chemokine ligand 5 (CCL5) and C-X-C motif chemokine ligand 10 (CXCL10), which is suppressed by the Mediator subunit MED23. We further found that the inhibition of Ccl5 and Cxcl10 expression by MED23 likely occurs because of G9a (also known as euchromatic histone-lysine N-methyltransferase 2 [EHMT2])-mediated H3K9 dimethylation of the target promoters. Collectively, these findings reveal hepatic MED23 as a key modulator of chemokine production and inflammatory responses and define the MED23-CCL5/CXCL10 axis as a potential target for clinical intervention in liver fibrosis.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Bile
/ Biology
/ Carbon Tetrachloride - pharmacology
/ Chemokine CXCL10 - metabolism
/ Collagen
/ Fibrosis
/ Histone-lysine N-methyltransferase
/ Inflammation - physiopathology
/ Ligands
/ Liver
/ Liver Cirrhosis - metabolism
/ Liver Cirrhosis - physiopathology
/ Lysine
/ Male
/ Mediator Complex - metabolism
/ Mediator Complex - physiology
/ Medicine and Health Sciences
/ Mice
/ Nuclear Receptor Subfamily 1, Group F, Member 1 - metabolism
